Inova Dwight and Martha Schar Cancer Institute is a clinical research site located in Fairfax, Virginia, United States 22031.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Inova Dwight and Martha Schar Cancer Institute has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma.
Sponsors: BioNTech SE, Halozyme Therapeutics, Tocagen Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Inova Dwight and Martha Schar Cancer Institute has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Inova Dwight and Martha Schar Cancer Institute has 5 clinical trials on record, with 2 currently active. Their work covers Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma.
Yes — Inova Dwight and Martha Schar Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.